| Patent Number |
Title Of Patent |
Date Issued |
| RE29019 |
Intruder detection system |
October 26, 1976 |
| An intruder detection system comprising a line adapted to be located substantially at ground level and consisting of an elongated high permeability magnetic core on which is wound a coil in the form of successive sections of respectively opposite winding handednesses, a high gain low |
| PP4511 |
Alga strain |
March 18, 1980 |
| An alga named Dunaliella bardawil is similar to D. salina except that its length is 15-19 .mu.m, its diameter 10-14 .mu.m and its volume 200-1000 .mu.m.sup.3, and it contains large quantities of carotene and glycerol. |
| 7428345 |
Apparatus and method for spatio-temporal alignment of image sequences |
September 23, 2008 |
| A method and system for aligning in at least one of time and space temporally ordered sequences of images comprising receiving a plurality of sequences of images, each sequence including a multiplicity of images, each plurality of sequences defining a space-time volume, and providing |
| 7271588 |
Method and apparatus for acquiring multidimensional spectra and improved unidimensional spectra |
September 18, 2007 |
| Method and apparatus for treating a sample to acquire multidimensional spectra within a single scan that partitions a sample into a set of independent subensembles endowed with different resonance frequencies. A polychromatic irradiation of the sample is implemented whereby the vario |
| 7240198 |
Honesty preserving negotiation and computation |
July 3, 2007 |
| A method and system for preserving the integrity of a negotiation that includes providing an architecture which includes a center A, and a plurality of users B.sub.1, B.sub.2, . . . , B.sub.n. each user B.sub.i generates an input X.sub.i, which is input to the center A. The center A |
| 7110903 |
Apparatus for monitoring a system with time in space and method therefor |
September 19, 2006 |
| Apparatus and method for monitoring a system in which a fluid flows and which is characterized by a change in the system with time in space. A preselected place in the system is monitored to collect data at two or more time points correlated to a system event. The data is indicative of |
| 7053178 |
Synthetic peptides and kits for diagnosis of anti-phospholipid syndrome |
May 30, 2006 |
| Synthetic peptides and derivatives thereof capable of inhibiting the biological activity of anti-beta-2-glycoprotein 1 (.beta.2GPI) monoclonal antibodies (mAbs) in vitro, and of inhibiting induction of experimental anti-phospholipid syndrome (APS) in mice by anti-.beta.2GPI mAbs, are |
| 6844314 |
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuro |
January 18, 2005 |
| Methods are provided for treating injury to or disease of the central or peripheral nervous system. In one embodiment, treatment is effected by administering activated T cells that recognize an antigen of Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to |
| 6553327 |
Apparatus for monitoring a system with time in space and method therefor |
April 22, 2003 |
| Apparatus and method for monitoring a system in which a fluid flows and which is characterized by a change in the system with time in space. A preselected place in the system is monitored to collect data at two or more time points correlated to a system event. The data is indicative of a |
| 6548124 |
Nanometric scale coherently controlled molecular deposition |
April 15, 2003 |
| A method for the controlled nanometer-scale deposition of molecules on a surface, by means of coherently controlled optical focusing. The coherent control is conveniently performed by inducing a linear superposition of molecular bound states, by means of electromagnetic fields supplied b |
| 6544506 |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
April 8, 2003 |
| A method of transplanting a transplant derived from a donor into a recipient is disclosed. The method comprises the steps of (a) transplanting the transplant into the recipient; and (b) administering to the recipient a dose including non-alloreactive anti-third party cytotoxic T-lymp |
| 6531816 |
Protection of photocathodes with thin film of cesium bromide |
March 11, 2003 |
| This invention discloses a thin-film-coated photocathode, including a photocathode formed of first material consisting of potassium cesiuin antimonide and a thin-film coating of a second material consisting of cesium bromide (CsBr). |
| 6254867 |
Human monoclonal antibodies to the hepatitis B surface antigen |
July 3, 2001 |
| Disclosed is a process for obtaining hybridoma cell lines which produce human antibodies capable of binding to the hepatitis B virus surface antigen (HBVsAg), as well as the hybridoma cell lines, and antibodies produced by the cell lines. Also disclosed are various uses of said antib |
| 6239107 |
Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
May 29, 2001 |
| The invention concerns novel conjugates of peptide fragments of vasoactive intestinal peptide (VIP) or analogues thereof having 3-12 amino acid residues, and lipophilic moieties, which may be present at the N- or C-terminus. The invention further concerns pharmaceutical compositions |
| 6185015 |
Compact planar optical correlator |
February 6, 2001 |
| A planar optical correlator including at least first and second optical substrates (30, 32), through which light propagates by means of total internal reflection, at least first and second holographic lenses (20, 22) on the first optical substrate and optical third and fourth holographic |
| 6160106 |
Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
December 12, 2000 |
| DNA molecules comprising a nucleic acid sequence expressed in cells, the expression product of which is involved in programmed cell death. Also disclosed are methods of therapeutic treatment using the DNA molecules and their expression products, and pharmaceutical compositions containing |
| 5966223 |
Planar holographic optical device |
October 12, 1999 |
| A holographic optical device having a light transmissive substrate with a first holographic optical element carried by the substrate, and a second holographic optical element also carried by the substrate but laterally offset from the first holographic optical element. The first holograp |
| 5962404 |
Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 factor |
October 5, 1999 |
| An enzymatically-producible dimeric IL-2 such as mammalian, more particularly, human dimeric IL-2, having oligodendrocyte cytotoxic activity, is useful as active ingredient of pharmaceutical compositions for inducing and facilitating regeneration of injured nerves of the central nerv |
| 5859197 |
Neurogene |
January 12, 1999 |
| Disclosed are DNA and amino acid sequences for a novel polypeptide termed Neuritin which is expressed primarily in selected regions of the brain. |
| 5858991 |
Facilitation of wound healing with CM101/GBS toxin |
January 12, 1999 |
| The method of the present invention provides a means of treating a patient having a wound, especially by minimizing scarring and accelerating wound healing, by administering CM101 or GBS toxin isolated from Group B .beta.-hemolytic streptococcus bacteria. The method of the present in |
| 5682255 |
Holographic optical devices for the transmission of optical signals of a plurality of channels |
October 28, 1997 |
| A holographic optical device includes a light-transmissive substrate, a first holographic optical element, and a second holographic optical element that is laterally disposed on the substrate from the first holographic optical element. At least one of the holographic optical elements |
| 5618700 |
IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same |
April 8, 1997 |
| The hybridoma 34-1 (CNCM I-813) which produces anti-human IL-6 monoclonal antibody 34-1 is disclosed. Methods of producing the monoclonal antibody and methods for affinity purification of human IL-6 using monoclonal antibody 34-1 are also described. |
| 5554514 |
Production of recombinant human interferon beta.sub.2.sbsb.B |
September 10, 1996 |
| Human interferon-beta.sub.2.sbsb.A and interferon-beta.sub.2.sbsb.B are produced in purified form by recombinant DNA techniques. Two separate human genes have been identified which code for the production of IFN-.beta..sub.2.sbsb.A and IFN-.beta..sub.2.sbsb.B, respectively. The seque |
| 5554513 |
Production of recombinant human interferon-beta.sub.2 |
September 10, 1996 |
| Human interferon-beta.sub.2.sbsb.A and interferon-beta.sub.2.sbsb.B are produced in purified form by recombinant DNA techniques. Two separate human genes have been identified which code for the production of IFN-.beta..sub.2.sbsb.A and IFN-.beta..sub.2.sbsb.B, respectively. The seque |
| 5541312 |
Production of interferon |
July 30, 1996 |
| The present invention .relates to a process to isolate genetic material (DNA) containing the nucleotide sequence coding for interferon in human fibroblastic cells which comprises cultivating cells producing interferon when exposed to an inducer of interferon, exposing same to such induce |
| 5526338 |
Method and apparatus for storage and retrieval with multilayer optical disks |
June 11, 1996 |
| A multilayer optical disk system, which includes an optical disk unit having a number of connected optical disks. A number of light sources, such as diode lasers, are used to provide a number of light beams of different wavelengths. A wavelength multiplexer combines the light beams i |
| 5514565 |
Enzymatically-produced dimeric IL-2 and a nerve-derived transglutaminase enzyme for its preparat |
May 7, 1996 |
| The invention provides a new nerve-derived transglutaminase enzyme that converts immune-derived IL-2 to dimeric IL-2 having oligodendrocyte cytotoxic activity. Both the nerve-derived transglutaminase and the dimeric mammalian, e.g. human, IL-2, are for use as active ingredients in ph |
| 5468609 |
Production of interferon |
November 21, 1995 |
| The present invention relates to a process to isolate genetic material (DNA) containing the nucleotide sequence coding for interferon in human fibroblastic cells which comprises cultivating cells producing interferon when exposed to an inducer of interferon, exposing same to such inducer |
| 5468608 |
Production of interferon |
November 21, 1995 |
| The present invention relates to a process to isolate genetic material (DNA) containing the nucleotide sequence coding for interferon in human fibroblastic cells which comprises cultivating cells producing interferon when exposed to an inducer of interferon, exposing same to such inducer |
| 5468607 |
Production of interferon |
November 21, 1995 |
| The present invention relates to a process to isolate genetic material (DNA) containing the nucleotide sequence coding for interferon in human fibroblastic cells which comprises cultivating cells producing interferon when exposed to an inducer of interferon, exposing same to such inducer |
| 5375170 |
Efficient signature scheme based on birational permutations |
December 20, 1994 |
| A birational permutation is a function f which is a one-to-one and onto mapping over k-tuples of numbers, where both f and its inverse are low degree rational functions. This patent describes a novel digital signature scheme which is based on a new class of birational permutations which |
| 5266476 |
Fibrous matrix for in vitro cell cultivation |
November 30, 1993 |
| There is provided a matrix and cultivation system for anchorage dependent cells. The matrix is characterized by a substantially increased available effective surface area for cell attachment which is attained by resorting to the use of a fiber network or open-pore foams with suitable por |
| 5263085 |
Fast signature scheme based on sequentially linearized equations |
November 16, 1993 |
| A new type of digital signature scheme whose security is based on the difficulty of solving systems of k polynomial equations in m unknowns modulo a composite n is proposed. The scheme uses a simple technique (called sequential linearization) for embedding trapdoors into such systems |
| 5194738 |
Apparatus for digital imaging |
March 16, 1993 |
| Apparatus for digital imaging including at least one electron multiplier arranged to receive beta radiation from a sample, apparatus for collimating the beta radiation without totally blocking all radiation from any location within a given region of interest on the sample, and readout |
| 5192861 |
X-ray imaging detector with a gaseous electron multiplier |
March 9, 1993 |
| An X-ray detector including a photocathode arranged to receive X-ray radiation and being operative to provide in response thereto an output of electrons, and at least one electron multiplier operative at subatmospheric pressure and in response to the output of electrons from the phot |
| 4999500 |
Apparatus for radiographic imaging |
March 12, 1991 |
| Apparatus for radiographic imaging including a multistage avalanche chamber receiving radiation from a multiplicity of radiation point sources on a sample and providing a multiple photon output indicative of the path of the emitted radiation through the avalanche chamber, image intensifi |
| 4996296 |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof |
February 26, 1991 |
| Substantially pure cromolyn binding protein is prepared by means of affinity chromatography of cromolyn derivatives bound to insoluble matrices. Aminocromolyn is prepared by a six-step synthesis and amine derivatives thereof are prepared by conventional means. Obtaining a compound ha |
| 4933294 |
Method of detecting truncated epidermal growth factor receptors |
June 12, 1990 |
| Neoplastic and other diseases can be diagnosed by assaying a human test sample e.g. body fluid, tissue or cultured tumor explant cells, for structurally altered or abnormally expressed growth factor receptors or for the RNA transcripts of genes which encode them. For example, the assay |
| 4931275 |
Anti-tumor vaccines and their preparation |
June 5, 1990 |
| There are provided anti-tumor vaccines which contain as active ingredient tumor cells which have been pressure treated so as to augment their antigenic properties, tumor cells treated with cholesteryl hemisuccinate (CHS) and subsequently pressure treated, or plasma membranes from either |
| 4910772 |
Video scrambling apparatus and method based on space filling curves |
March 20, 1990 |
| A method of encrypting a video signal employing a pseudo-random Space Filling Curve having a highly irregular scanning pattern for scanning the pixel addresses of a video picture stored in a frame buffer. The method is used with a video scrambler/descrambler device and is characterized b |
| 4889803 |
Production of interferon gamma |
December 26, 1989 |
| Interferon .gamma. is produced in highly purified form (activity exceeding 10.sup.8 units/ml-day) by CHO cells cotransformed by a first plasmid bearing the genomic human interferon gene under the control of the SV40 early promoter, and a second plasmid bearing a DHFR gene under similar |
| 4800060 |
Window assembly for positron emitter |
January 24, 1989 |
| There are provided container vessels for the production and transportation of short-lived isotopes by irradiation from an accelerator, comprising a hermetically sealed container with a window in one of its walls which fits the exit window of such accelerator, and through which a suitable |
| 4785587 |
Novel lap for the polishing of gem stones |
November 22, 1988 |
| There is provided a scaife for the polishing of gemstones wherein the abrasive material is embedded in a matrix of a material maintained in the solid state, which material has a high enthalpy of phase transition from solid to liquid. Suitable materials are frozen water, frozen water/orga |
| 4751064 |
Synthetic chollera vaccine |
June 14, 1988 |
| A synthetic vaccine against cholera and against heat-labile toxin of E. coli comprising a conjugate of a high-molecular weight carrier with a synthetic polypeptide corresponding to part of the sequence of Subunit B of natural cholera toxin. The sequences of choice are those corresponding |
| 4748286 |
Production of crystalline tribromostyrene |
May 31, 1988 |
| The invention relates to an improved process for the production of crystalline tribromostyrene. The process involves removal of hydrogen bromide in a two phase system with the aid of phase transfer catalysts. One of the phases used is an aqueous one containing an alkali metal hydroxi |
| 4673260 |
Stereoscopic optical device |
June 16, 1987 |
| Stereoscopic binocular apparatus comprising first and second optical axes and means for arranging the first and second optical axes in the plane defined thereby whereby they converge at the location of the object being viewed. |
| 4552922 |
Method for multipolymer synthesis of organic compounds |
November 12, 1985 |
| A broad range of organic synthesis reactions can be conducted by means of a process using two polymeric supports, each carrying different reactive species. A liquid medium containing a specifically selected intermediate reactant, in a solvent, is circulated between the supports in order |
| 4491932 |
Associative processor particularly useful for tomographic image reconstruction |
January 1, 1985 |
| In an associative processor particularly useful for tomographic image reconstruction, the associative memory is partitioned into an array of associative processors concurrently performing the same function with different operands on disjoint data sets. The array is dynamically reconf |
| 4474757 |
Synthetic vaccine and process for producing same |
October 2, 1984 |
| There is provided a synthetic vaccine against influenza virus infections consisting of a synthetic peptide corresponding to a relevant antigenic fragment of the virus, which fragment is attached to a suitable carrier, such as a macromolecule. Effective vaccinations against a plurality of |
| 4458694 |
Apparatus and method for detection of tumors in tissue |
July 10, 1984 |
| Apparatus for detecting tumors in living human breast tissue comprising apparatus for determining the dielectric constants of localized regions of living human breast tissue including probe apparatus comprising a multiplicity of probe elements, apparatus for applying an AC signal to the |
